Sequence is celebrating our 20th Anniversary!

Watch the Video
All Projects

Train 2 Commercialization: Commissioning and Installation / Operational Qualification

Vaccine Facility


The Pfizer Sanford, NC facility is responsible for manufacturing components for the company’s vaccine portfolio, including Prevnar 13.

Sequence Scope

Train 2 was designed and validated to support full‐scale development activities for a multi‐product portfolio capable of producing purified bacterial polysaccharides and proteins, as well as glyco‐conjugates suitable for use in clinical trials.
The Train 2 manufacturing area is divided into process areas such as: Media, Buffer, Fermentation, Recovery, Purification, Alcohol and Chemistry.

Sequence was responsible providing the planning, strategy, and execution of C&Q deliverables to support the scale up of the existing facility to enable commercialization of existing product lines. The specific scope included various support functions such as development of the first Automation Commissioning strategy for the site, risk assessments based on FMEA analysis, and development and/or updates to automation specifications on a DeltaV controls platform.

Life Impact

  • As a result of this project, the Pfizer facility will continue to manufacture components for various vaccines, such as Prevnar 13

Get Started

How can we support your project success?

Contact Us
  • Global Headquarters
    2100 Gateway Center Blvd, Suite 301
    Morrisville, NC 27560

  • Northeast Office
    1 Speen Street, Suite 120
    Framingham, MA 01701

Sign up for our email newsletter
white sequence logo

Accelerating time to market through proven quality and compliance solutions.

© 2022 Sequence, Inc. All rights reserved.